What is Scheer Partners?
Scheer Partners operates as a premier full-service commercial real estate firm with a deep-rooted presence in the Washington, D.C. and Philadelphia markets. With over thirty years of industry experience, the company has cultivated a specialized niche in the scientific, biotech, and healthcare sectors, providing sophisticated solutions that address the complex infrastructure requirements of these high-growth industries. Their service portfolio is comprehensive, spanning agency leasing, property management, project development, and capital markets advisory. By maintaining an integrated team of seasoned brokers, Scheer Partners delivers tailored, high-impact results that cater to the unique operational needs of its diverse client base, ranging from industrial developers to retail property owners.
How much funding has Scheer Partners raised?
Scheer Partners has raised a total of $354K across 2 funding rounds:
Debt
$150K
Debt
$204K
Debt (2020): $150K with participation from PPP
Debt (2021): $204K led by PPP
Key Investors in Scheer Partners
PPP
Public-Private Partnership
What's next for Scheer Partners?
With the infusion of recent capital, Scheer Partners is well-positioned to accelerate its strategic initiatives within the competitive Mid-Atlantic landscape. The firm is expected to prioritize the expansion of its project development pipeline, particularly in the high-demand biotech and life sciences sectors where specialized facility requirements are increasing. Furthermore, the company will likely leverage its strengthened balance sheet to enhance its capital markets capabilities, providing clients with more robust financial advisory services. As the firm continues to scale, the focus will remain on maintaining its reputation for excellence in property management and agency leasing, while potentially exploring new geographic markets that align with its expertise in complex, mission-critical real estate assets.
See full Scheer Partners company page
